Enflurane

drugbox
IUPAC_name = 2-chloro-1-(difluoromethoxy)-1,1,2-trifluoro-ethane

---

CAS_number = 13838-16-9
ATC_prefix = N01
ATC_suffix = AB04
ATC_supplemental =
PubChem = 3226
DrugBank = APRD00234
C=3 | H=2 | Cl=1 | F=5 | O=1
molecular_weight = 184.492 g/mol
bioavailability =
protein_bound = 97%
metabolism =
elimination_half-life =
pregnancy_category =
legal_status =
routes_of_administration =

Enflurane (2-chloro-1,1,2,-trifluoroethyl-difluoromethyl ether) is a halogenated ether that was commonly used for inhalational anesthesia during the 1970s and 1980s. Developed by Ross Terrell in 1963, it was first used clinically in 1966.

Enflurane is a structural isomer of isoflurane. It vaporizes readily, but is a liquid at room temperature.

Physical properties

ide Effects

Clinically, enflurane produces a dose-related depression of myocardial contractility with an associated decrease in myocardial oxygen consumption. Between 2% and 5% of the inhaled dose is oxidised in the liver, producing fluoride ions and difluoromethoxy-difluoroacetic acid. This is significantly higher than the metabolism of its structural isomer isoflurane.

Enflurane also lowers the threshold for seizures and should especially not be used on people with epilepsy. It is also known to cause malignant hyperthermia.

Relaxes the uterus (can cause spontaneous birth) in pregnant woman.

Enflurane and Methoxyflurane have a nephrotoxic effect and cause acute renal failure usually by its nephrotoxic metabolite. By G. Edward Morgan, Maged S. Mikhail, Michael J. Murray, C. Philip Larson; clinical anaesthesiology third edition,142.

External links